These ASX shares can rise 25% to 100%+

Analysts think these shares could deliver big returns for investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking for big returns for your investment portfolio?

If you are, then take a look at the three ASX shares listed below that have been tipped to rise materially by analysts.

Here's what you need to know about them:

A man looks surprised as a woman whispers in his ear.

Image source: Getty Images

AVITA Medical Inc (ASX: AVH)

Morgans sees huge upside for this ASX share over the next 12 months. In fact, the broker believes the regenerative medicine company could more than double in value from current levels.

It was very pleased with news that the US FDA has approved its Recell Go product. It is an autologous cell harvesting device, harnessing the regenerative properties of a patient's own skin to treat burn wounds and full-thickness skin defects. It commented:

AVH has received FDA approval for its automated product, RECELL Go, for use in burns and full thickness skin defects. This approval marks a significant milestone for the company, with management expecting this device to increase adoption of the technology amongst clinicians. We have made no changes to our forecasts and recommendation.

Morgans has an add rating and $6.40 price target on its shares. This implies potential upside of 115% for investors.

Champion Iron Ltd (ASX: CIA)

Analysts at Goldman Sachs think that this miner would be a great option for investors that are looking for exposure to iron ore. The broker feels its shares are undervalued at the current level and could offer major upside potential and good dividend yields. It said:

Supportive Valuation: the stock is trading at 0.8x NAV (A$8.8/sh) and ~4.4x EBITDA (NTM). Our NAV is based on a long run Fe price of ~US$105/t (real) for 65% Fe and ~US$75/t premium for DRPF above 62% Fe Index. For every ~US$10/t increase in our long run price, our CIA NAV would increase by ~A$1.5/sh.

Goldman has a buy rating and $8.80 price target on its shares. This implies potential upside of 25% for investors. In addition, it is forecasting dividend yields of 4% in FY 2025 and 6% in FY 2026.

Eagers Automotive Ltd (ASX: APE)

Another ASX share that could offer big returns is Eagers Automative. It operates one of Australia's largest auto dealership networks.

Bell Potter thinks that the company's shares have been oversold following a disappointing trading update last month. It said:

We believe this is a relatively isolated event that doesn't materially change the outlook so our investment thesis remains intact. We believe the stock looks value on a 2025 PE ratio of c.10x and a forecast yield of c.6% in 2024 and c.7% in 2025.

Its analysts have a buy rating and $13.35 price target on its shares. This implies potential upside of 32% for investors. In addition, dividend yields of 6%+ are forecast through to FY 2026.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical and Goldman Sachs Group. The Motley Fool Australia has recommended Avita Medical and Eagers Automotive Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A young man goes over his finances and investment portfolio at home.
Broker Notes

NextDC vs Wesfarmers shares: Which is a buy?

Analysts have given their verdict on these shares this week.

Read more »

Three smiling corporate people examine a model of a new building complex.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

Up 130% in a year, are Lynas Rare Earths shares still a good buy today?

Lynas Rare Earths shares have more than doubled ASX investors’ money in a year. Is there still time to buy?

Read more »

Woman chooses vegetables for dinner, smiling and looking at camera.
Broker Notes

3 reasons to buy Coles shares today

A leading analyst expects Coles shares are well-placed to outperform. But why?

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Broker Notes

Why did Morgans just lower its outlook on Collins Food and Pro Medicus shares?

Despite lowering its guidance, these stocks remain undervalued according to at least one expert.

Read more »

Business people discussing project on digital tablet.
Broker Notes

BHP vs Coles shares: Which is the better buy this week?

Let's see which one of these giants is being recommended as a buy by analysts.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »